Global Epithelial Cell Adhesion Molecule Market Growth (Status and Outlook) 2023-2029

Global Epithelial Cell Adhesion Molecule Market Growth (Status and Outlook) 2023-2029

Epithelial cell adhesion molecule is a transmembrane glycoprotein mediating Ca2+-independent homotypic cell–cell adhesion in epithelia.EpCAM is also involved in cell signaling,migration,proliferation, and differentiation.Additionally, EpCAM has oncogenic potential via its capacity to upregulate c-myc, e-fabp, and cyclins A & E.Since EpCAM is expressed exclusively in epithelia and epithelial-derived neoplasms, EpCAM can be used as diagnostic marker for various cancers. It appears to play a role in tumorigenesis and metastasis of carcinomas, so it can also act as a potential prognostic marker and as a potential target for immunotherapeutic strategies.

LPI (LP Information)' newest research report, the “Epithelial Cell Adhesion Molecule Industry Forecast” looks at past sales and reviews total world Epithelial Cell Adhesion Molecule sales in 2022, providing a comprehensive analysis by region and market sector of projected Epithelial Cell Adhesion Molecule sales for 2023 through 2029. With Epithelial Cell Adhesion Molecule sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Epithelial Cell Adhesion Molecule industry.

This Insight Report provides a comprehensive analysis of the global Epithelial Cell Adhesion Molecule landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Epithelial Cell Adhesion Molecule portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Epithelial Cell Adhesion Molecule market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Epithelial Cell Adhesion Molecule and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Epithelial Cell Adhesion Molecule.

The global Epithelial Cell Adhesion Molecule market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Epithelial Cell Adhesion Molecule is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Epithelial Cell Adhesion Molecule is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Epithelial Cell Adhesion Molecule is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Epithelial Cell Adhesion Molecule players cover Cell Signaling Technology, BioLegend, Thermo Fisher Scientific, Sino Biological, ACROBiosystems, R&D Systems and OriGene Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Epithelial Cell Adhesion Molecule market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Primary Structure
Secondary Structure
Other

Segmentation by application
Laboratory
Medical Care
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cell Signaling Technology
BioLegend
Thermo Fisher Scientific
Sino Biological
ACROBiosystems
R&D Systems
OriGene Technologies

Please note: The report will take approximately 2 business days to prepare and deliver.